Arno Therapeutics (OTCMKTS:ARNI) Stock Price Passes Above 50-Day Moving Average – What’s Next?

Arno Therapeutics, Inc. (OTCMKTS:ARNI) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.

Arno Therapeutics Stock Performance

Arno Therapeutics Company Profile

Arno Therapeutics, Inc (OTCMKTS:ARNI) is a development‐stage biopharmaceutical company focused on the research and development of targeted therapeutics for oncology indications and rare genetic disorders. The company’s mission is to apply innovative biologic and protein engineering platforms to create therapies that address significant unmet medical needs in cancer and inherited metabolic conditions.

Arno’s pipeline centers on antibody‐based drug conjugates and recombinant fusion proteins designed to selectively target tumor cells or restore deficient enzyme activity in rare diseases.